Abbott Laboratories Completes Acquisition of Exact Sciences, Expands Leadership in Cancer Screening and Diagnostics

Abbott Laboratories (ABT) has completed the acquisition of Exact Sciences, solidifying its position as a leader in cancer screening and diagnostics. This adds a new growth vertical to its already high-single-digit growth outlook, establishing leadership in the expanding $60 billion US market. Abbott Laboratories' global scale and history of operational and commercial excellence will help expand accessibility to tools for early cancer detection and personalized treatments.